SCHEMBL14712359

SCHEMBL14712359

CNCCCCCCC1(C)CC(=O)OB([C@H](CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)c2cnccn2)OC(=O)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB5 P28074 16/20 0.56
▸ PSMB1 P20618 12/20 0.52
▸ PSMB2 P49721 11/20 0.52
▸ PSMB11 A5LHX3 10/20 0.52
▸ PSMA7 O14818 10/20 0.52
▸ PSMA1 P25786 10/20 0.52
▸ PSMA2 P25787 10/20 0.52
▸ PSMA3 P25788 10/20 0.52
▸ PSMA4 P25789 10/20 0.52
▸ PSMB8 P28062 10/20 0.52
▸ PSMB9 P28065 10/20 0.52
▸ PSMA5 P28066 10/20 0.52
▸ PSMB4 P28070 10/20 0.52
▸ PSMB6 P28072 10/20 0.52
▸ PSMB10 P40306 10/20 0.52
▸ PSMB3 P49720 10/20 0.52
▸ PSMA6 P60900 10/20 0.52
▸ PSMA8 Q8TAA3 10/20 0.52
▸ PSMB7 Q99436 10/20 0.52
▸ LONP1 P36776 9/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12180817 1.00 PSMB5 (0.56) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL464479 0.85 ERBB2 (0.62) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL13130797 0.85 ERBB2 (0.62) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL20093557 0.85 ERBB2 (0.62) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL14754702 0.85 ERBB2 (0.62) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL18316268 0.85 PSMB5 (0.62) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL18316270 0.85 PSMB5 (0.62) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL18316250 0.84 PSMB5 (0.60) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL21210343 0.84 PSMB5 (0.63) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL21210524 0.84 PSMB5 (0.63) PSMB5PSMB1PSMB2PSMB11PSMA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013025490-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES CERULEAN PHARMA INC. (US) 2013-02-21 — — WO disclosed
Send feedback